Little Green Pharma Ltd (ASX: LGP) Share Price and News

Dr Fong is a registered medical practitioner with over 35 years in senior leadership roles in private hospitals, the public health systems, management consulting, academia, health research, aged care and not for profit organisations. Neale is currently CEO of Bethesda Health Care and formerly was Director General of the West Australian Department of Health. Neale is an ASX company director and is currently independent chair of Intelicare. He is a former nonexecutive director of Neurotech International and executive chair of Chrysalis Resources and has been a Fellow of the Australian Institute of Company Directors since 2001. Neale is also Chair of the Company's Risk Committee.

Mr Caithness is a corporate finance executive and consultant in Australia and international markets. Angus has ASX experience as a non-executive Director of Lindian Resources CFO of Hunnu Coal and Company Secretary for the IPO of Haranga Resources. Following these roles, Angus acted as CFO of Tavan Tolgoi, the owner of the coking coal deposit looking at a US$10bn dual listing in London and Hong Kong prior to the change in the Mongolian government.

Ms Solomon drives the strategic vision of the business and as Chief Executive Officer of Little Green Pharma has grown the company from a medicinal cannabis startup to an industry medicinal cannabis brand in Australia and overseas. Fleta has 20 years of experience in corporate and consumer health markets.

Mr Lynch-Bell is a corporate finance executive and consultant. Michael was appointed on 13 November 2018. His early Ernst and Young career were focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Michael also led Ernst and Young's UK IPO and Global Natural Resources transaction teams in the Transaction Advisory practice. He has been involved advising companies on fundraising, re-organizations, transactions, corporate governance as well as IPOs.

Ms Banzo Has over 30 years working in the European pharmaceutical industry, Beatriz is an experienced and decorated expert in European pharmaceutical regulatory and quality assurance matters. Prior to joining LGP, Beatriz was the Director of Public Affairs (Market Access and Patient Advocacy), Regulatory and Quality Assurance for Bayer Pharmaceuticals and Consumer Health in Spain, Head of Regulatory Affairs and Permanent Executive Committee Guest at Novartis Pharmaceutical Company.

-

-